Pluri Inc. Available-for-sale Securities, Gross Unrealized Loss
Pluri Inc. (PLUR) reported Available-for-sale Securities, Gross Unrealized Loss of -$137.00 thousand for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss · last filed 2013-11-05
- Pluri Inc. available-for-sale securities, gross unrealized loss for the quarter ending 2013-09-30 was -$137.00K.
- Pluri Inc. available-for-sale securities, gross unrealized loss for fiscal 2012 was -$58.00K.
| Period end | Available-for-sale Securities, Gross Unrealized Loss 3 month | Available-for-sale Securities, Gross Unrealized Loss 12 month | Available-for-sale Securities, Gross Unrealized Loss 12 month as first filed |
|---|---|---|---|
| 2013-09-30 | -$137.00K 10-Q · filed 2013-11-05 | ||
| 2013-06-30 | -$311.00K 10-Q · filed 2013-11-05 | -$189.00K 10-K · filed 2013-09-11 | |
| 2012-06-30 | -$58.00K 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |